Associated Papers
Crystal structure of Alzheimer's disease phospholipase D3 provides a molecular basis for understanding its normal and pathological functions.
Ishii K et al.
The Febs Journal, 2024
Structural analysis of PLD3 reveals insights into the mechanism of lysosomal 5' exonuclease-mediated nucleic acid degradation.
Roske Y et al.
Nucleic Acids Research, 2024
Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population.
Li Y et al.
Journal of Alzheimer's Disease : Jad, 2024
Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism.
Van Acker ZP et al.
Nature Communications, 2023
Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.
Cacace R et al.
Human Mutation, 2015
Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer's disease.
Schulte EC et al.
Human Genome Variation, 2015
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.
Cruchaga C et al.
Nature, 2014
Quantification and characterization of the 5' exonuclease activity of the lysosomal nuclease PLD3 by a novel cell-based assay.
Cappel C et al.
The Journal of Biological Chemistry, 0
Select a paper to view details